当前位置:首页 - 行情中心 - 联环药业(600513) - 财务分析

联环药业

(600513)

  

流通市值:25.41亿  总市值:25.41亿
流通股本:2.85亿   总股本:2.85亿

联环药业(600513)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润1.51亿元,每股收益0.47元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益151731.03万元,未分配利润71226.46万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产285570.23万元,负债133839.21万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入2,174,100,305.521,483,405,300.86954,649,770.62451,680,716.64
营业总成本2,016,158,761.631,371,969,771.26882,109,946.92413,066,960.92
营业利润174,771,965.14117,398,003.9977,477,727.2341,538,555.66
利润总额175,032,056.82116,852,492.4477,039,432.3141,631,975.43
净利润151,340,323.71100,597,014.2867,702,022.3635,060,507.57
其他综合收益-195,308.71---
综合收益总额151,145,015100,597,014.2867,702,022.3635,060,507.57
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计1,353,403,011.171,339,905,715.111,342,528,782.091,329,769,264.87
非流动资产合计1,502,299,302.61,465,561,896.91,413,623,870.251,377,175,321.07
资产总计2,855,702,313.772,805,467,612.012,756,152,652.342,706,944,585.94
流动负债合计1,246,521,384.61,259,787,6431,261,730,775.741,200,125,273.87
非流动负债合计91,870,665.8778,917,707.0257,958,706.4457,165,226.87
负债合计1,338,392,050.471,338,705,350.021,319,689,482.181,257,290,500.74
归属于母公司股东权益合计1,354,189,077.51,308,217,672.441,283,499,537.211,298,604,952.11
股东权益合计1,517,310,263.31,466,762,261.991,436,463,170.161,449,654,085.2
负债和股东权益合计2,855,702,313.772,805,467,612.012,756,152,652.342,706,944,585.94
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计2,356,201,227.321,616,189,760.851,040,485,788.35519,928,021.58
经营活动现金流出小计2,195,499,431.831,626,834,848.871,035,067,993.61535,954,414.81
经营活动产生的现金流量净额160,701,795.49-10,645,088.025,417,794.74-16,026,393.23
投资活动现金流入小计28,479,115.6826,962,439.233,456,939.23-
投资活动现金流出小计213,172,997.31158,664,321.91103,532,633.2147,453,146.95
投资活动产生的现金流量净额-184,693,881.63-131,701,882.68-100,075,693.98-47,453,146.95
筹资活动现金流入小计719,819,000449,690,000291,190,000119,650,000
筹资活动现金流出小计754,916,867.47440,980,277.03317,387,544.37128,751,987.01
筹资活动产生的现金流量净额-35,097,867.478,709,722.97-26,197,544.37-9,101,987.01
汇率变动对现金及现金等价物的影响232,221.81422,026.06360,228.73-249,922.34
现金及现金等价物净增加额-58,857,731.8-133,215,221.67-120,495,214.88-72,831,449.53
期末现金及现金等价物余额250,190,022.57175,832,532.7188,552,539.49236,216,304.84
TOP↑